Application no. and date | 10776998.6 (espacenet) (Federated) (European Patent Register), 20101111 | Patent/reg. no. and date | DK/EP 2498802, 20150107 | Publication date | 20120919 | Priority no. and date | DE 102009052831, 20091113, DE 102010020902, 20100518 | EP pub. no. and date |
EP 2498802 20120919 | Effective date | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50 65929 Frankfurt am Main, DE | Applicant ref. no. | Sanofi DE2009/205-EP-EPT | Inventor | SCHOETTLE, Isabell, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE, SIEFKE-HENZLER, Verena, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE, HAUCK, Gerrit, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE, HAGENDORF, Annika, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE, MÜLLER, Werner, c/o Sanofi-Aventis Deutschland GmbH
65926Frankfurt am Main, DE, TERTSCH, Katrin, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61K 47/20 (2006.01) , A61P 3/10 (2006.01) | Title | FARMACEUTISK PRÆPARAT OMFATTENDE EN GLP-1-AGONIST, ET INSULIN OG EN METHIONIN | Int. application no. | EP2010067250 | Int. publication no. | WO2011058083 | Related patent (certificate) | CA 2017 00020 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|